HelloBetter is a European leader in evidence-based digital therapeutics (DTx) for mental health. Founded in 2015, the company develops prescription digital therapeutics (PDTx/DiGA) and AI-supported mental health products to make psychological care accessible, scalable and clinically effective.

We create clinically validated online therapy programs and digital companions (for example HelloBetter DiGAs and the Ello AI companion) used in routine care, often available by prescription. HelloBetter has published numerous randomized controlled trials and integrates licensed clinicians with digital interventions to ensure safety and measurable outcomes.

Several HelloBetter programs are listed in Germany’s standard of care and available to millions via prescription. The company expanded to the US with HelloGina and has received regulatory recognition such as FDA Breakthrough Device Designation for HelloBetter Panic. Headquartered in Berlin, HelloBetter combines research, clinical practice and engineering to reduce barriers to mental health care.